Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness.

Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S.

PLoS One. 2012;7(2):e31316. doi: 10.1371/journal.pone.0031316. Epub 2012 Feb 8.

2.

Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya.

Kahn JG, Harris B, Mermin JH, Clasen T, Lugada E, Grabowksy M, Vestergaard Frandsen M, Garg N.

BMC Health Serv Res. 2011 Dec 21;11:346. doi: 10.1186/1472-6963-11-346.

3.

A qualitative assessment of beliefs, attitudes, and behaviors related to diarrhea and water filtration in rural Kenya.

De Ver Dye T, Apondi R, Lugada E, Kahn JG, Sandiford-Day MA, Dasbanerjee T.

Am J Public Health. 2011 Aug;101(8):1515-20. doi: 10.2105/AJPH.2011.300127. Epub 2011 Jun 16.

4.
5.

"Before we used to get sick all the time": perceptions of malaria and use of long-lasting insecticide-treated bed nets (LLINs) in a rural Kenyan community.

Dye TD, Apondi R, Lugada ES, Kahn JG, Smith J, Othoro C.

Malar J. 2010 Nov 30;9:345. doi: 10.1186/1475-2875-9-345.

6.

Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya.

Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, Kahn JG, Muraguri N, Mermin J.

PLoS One. 2010 Aug 26;5(8):e12435. doi: 10.1371/journal.pone.0012435. Erratum in: PLoS One. 2011;6(6). doi:10.1371/annotation/b3e1590a-5814-4848-958e-2af40d318936. Khan, James G [corrected to Kahn, James G]. PLoS One. 2010;5(9). doi: 10.1371/annotation/cd255375-7cf9-4b56-a81f-ec57e360c472. Kahn, James [corrected to Khan, James G].

7.

Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial.

Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G, Gupta S, Grosskurth H, Jaffar S, Coutinho A, Bunnell R.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):245-52. doi: 10.1097/QAI.0b013e3181e9e069.

PMID:
20714273
8.

Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda.

Bunders M, Lugada E, Mermin J, Downing R, Were W, Thorne C, Newell ML; European Collaborative Study.

Ann Trop Paediatr. 2006 Sep;26(3):169-79.

PMID:
16925953
9.

Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway.

Lugada ES, Mermin J, Asjo B, Kaharuza F, Downing R, Langeland N, Ormaasen V, Bruun J, Awor AC, Ulvestad E.

Scand J Immunol. 2004 Feb;59(2):203-8.

PMID:
14871298
10.

Population-based hematologic and immunologic reference values for a healthy Ugandan population.

Lugada ES, Mermin J, Kaharuza F, Ulvestad E, Were W, Langeland N, Asjo B, Malamba S, Downing R.

Clin Diagn Lab Immunol. 2004 Jan;11(1):29-34.

11.

Diarrhea, CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in Uganda.

Brink AK, Mahé C, Watera C, Lugada E, Gilks C, Whitworth J, French N.

J Infect. 2002 Aug;45(2):99-106.

PMID:
12217712
12.

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults.

French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, Lalloo D, Whitworth JA, Gilks CF.

AIDS. 2002 May 3;16(7):1031-8.

PMID:
11953469
13.

Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda.

Lugada ES, Watera C, Nakiyingi J, Elliott A, Brink A, Nanyunja M, French N, Antivelink L, Gilks C, Whitworth J.

Int J Tuberc Lung Dis. 2002 Apr;6(4):326-31.

PMID:
11936742
14.

Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.

French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF.

AIDS. 2001 May 4;15(7):899-906.

PMID:
11399962
15.

Rhodococcus equi and HIV-1 infection in Uganda.

Gray KJ, French N, Lugada E, Watera C, Gilks CF.

J Infect. 2000 Nov;41(3):227-31.

PMID:
11120609
16.

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial.

French N, Nakiyingi J, Carpenter LM, Lugada E, Watera C, Moi K, Moore M, Antvelink D, Mulder D, Janoff EN, Whitworth J, Gilks CF.

Lancet. 2000 Jun 17;355(9221):2106-11.

PMID:
10902624
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk